Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Videos
Videos
Thesis submission
Thesis submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Contact us
Contact us
Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension
Date
2020-03-01
Author
Perry, Helen
Binder, Julia
Kalafat, Erkan
Jones, Stuart
Thilaganathan, Basky
Khalil, Asma
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
9
views
0
downloads
Cite This
Angiogenic markers such as PlGF (placental growth factor) and sFlt-1 (soluble Fms-like tyrosine kinase-1) have been shown to be useful for predicting adverse outcome in women suspected of having preeclampsia. The aim of the current study was to evaluate the prognostic value of angiogenic markers and maternal risk factors in pregnant women with hypertension. This was a prospective study of pregnancies complicated by preeclampsia, gestational hypertension, or chronic hypertension presenting to 1 of 2 tertiary referral hospitals between May 2013 and May 2018. Maternal characteristics along with blood samples for angiogenic marker analysis were obtained from participants. The primary outcome was delivery related to preeclampsia within 1 and 2 weeks. In total, 302 women with hypertension were included in the study cohort. The baseline model included maternal body mass index, mean arterial pressure, and clinical diagnosis at the time of assessment. The use of sFlt-1/PIGF ratio combined with the baseline model significantly improved the area under the curve values for predicting delivery within a week (0.83 versus 0.88; P=0.025) or in 2 weeks (0.86 versus 0.93; P=0.001) due to preeclampsia-related events in gestational ages <35 weeks. The magnitude of increase in accuracy was 7.9% (-0.5% to 16.4%, posterior probability of increase: 96.7%) for sFlt-1/PlGF ratio. Our results emphasize the additive value of angiogenic biomarkers and the superior performance of a continuous scale of sFlt-1/PlGF ratio in the model. The added utility of angiogenic markers diminishes after 35 weeks' gestation.
Subject Keywords
Internal Medicine
URI
https://hdl.handle.net/11511/68323
Journal
HYPERTENSION
DOI
https://doi.org/10.1161/hypertensionaha.119.13997
Collections
Department of Statistics, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
H. Perry, J. Binder, E. Kalafat, S. Jones, B. Thilaganathan, and A. Khalil, “Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension,”
HYPERTENSION
, vol. 75, no. 3, pp. 755–761, 2020, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/68323.